Diabetes Mellitus and Cardiovascular Disease

Abstract

Get full access to this article

View all access options for this article.

References

1. Herrick JB . Clinical features of sudden obstruction of the arteries. JAMA. 1912; 59:2010-2015.

2. Scandinavian Simvastatin Survival Study Group . Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Survival Study (4S) Group. Lancet. 1994;344: 1383-1389.

3. Shepard J , Cobbe SM , Ford I , et al, for the West of Scotland Coronary Primary Prevention Group . Promotion of coronary artery disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995; 333:1301-1307.

4. Sacks FM , Pfeffer MA , Moye AA , et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;334: 1001-1009.

5. The Long Term Intervention With Pravastatin in Ischemic Disease (LIPID) Study Group . Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339: 1349-1358.

6. Downs JR , Clearfield M , Weis S , et al, for the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Research Group . Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol revels. JAMA. 1998;279: 1615-1622.

7. Campbell NC , Thain J , Deans HG . Secondary prevention in coronary heart disease: baseline survey of provisions in general practice. Br Med J. 1998;316: 1400-1401.

8. Campbell JA . Aspirin therapy in diabetes. Diabetes Care. 1996;20: 1767-1771.

9. Ikonomids I , Andrepotti F , Stephanadis C , et al. Reduction of cytokines and platelet aggregation by aspirin causes reduction of daily life ischemia in stable angina [abstract]. Circulation. 1999;100:1387-1387.

10.

10. Hansson L , Zanchetti A , Carruthers SG , et al. Effects of intensive bloodpressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment(HOT) Randomized Trial. Lancet. 1998;351:1755-1762.

11.

11. Antiplatelet Trialist Collaboration . Collaborative overview of randomized trials of antiplatelet therapy: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J. 1994;308:81-106.